Correlation Between Ekso Bionics and Mangoceuticals, Common

Can any of the company-specific risk be diversified away by investing in both Ekso Bionics and Mangoceuticals, Common at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ekso Bionics and Mangoceuticals, Common into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ekso Bionics Holdings and Mangoceuticals, Common Stock, you can compare the effects of market volatilities on Ekso Bionics and Mangoceuticals, Common and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ekso Bionics with a short position of Mangoceuticals, Common. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ekso Bionics and Mangoceuticals, Common.

Diversification Opportunities for Ekso Bionics and Mangoceuticals, Common

-0.5

Correlation Coefficient

Ekso Bionics  Mangoceuticals, Common

Very good diversification

The 3 months correlation between Ekso and Mangoceuticals, is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Ekso Bionics Holdings and Mangoceuticals, Common Stock in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mangoceuticals, Common and Ekso Bionics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ekso Bionics Holdings are associated (or correlated) with Mangoceuticals, Common. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mangoceuticals, Common has no effect on the direction of Ekso Bionics i.e., Ekso Bionics and Mangoceuticals, Common go up and down completely randomly.

Pair Corralation between Ekso Bionics and Mangoceuticals, Common

Given the investment horizon of 90 days Ekso Bionics Holdings is expected to under-perform the Mangoceuticals, Common. But the stock apears to be less risky and, when comparing its historical volatility, Ekso Bionics Holdings is 1.5 times less risky than Mangoceuticals, Common. The stock trades about -0.06 of its potential returns per unit of risk. The Mangoceuticals, Common Stock is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  242.00  in Mangoceuticals, Common Stock on December 31, 2024 and sell it today you would lose (4.00) from holding Mangoceuticals, Common Stock or give up 1.65% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Ekso Bionics Holdings  vs.  Mangoceuticals, Common Stock

Ekso Bionics Holdings

Risk-Adjusted Performance

Very Weak

Over the last 90 days Ekso Bionics Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in May 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Mangoceuticals, Common

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Mangoceuticals, Common Stock are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Mangoceuticals, Common showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Ekso Bionics and Mangoceuticals, Common

The main advantage of trading using opposite Ekso Bionics and Mangoceuticals, Common positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ekso Bionics position performs unexpectedly, Mangoceuticals, Common can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mangoceuticals, Common will offset losses from the drop in Mangoceuticals, Common's long position.

The idea behind Ekso Bionics Holdings and Mangoceuticals, Common Stock pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.